Coronavirus Update: No Sign Of Agreement In EU's Bitter Row With AstraZeneca Over Vaccine Supplies
Plus: GSK and Vir Team Up With Lilly On Antibody Combination
The dispute over a likely 60% reduction in supplies of AstraZeneca's COVID-19 vaccine shows no sign of resolution. Meanwhile, Lilly, Vir/GSK team up on COVID-19 antibody combination and Moderna negotiates sale of 100 million additional vaccine doses to US.
